Skip to main content
Nxera Pharma Co., Ltd. logo

Nxera Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 4565 ISIN · JP3431300007 LEI · 2138004M62BFNJMR2Z82 T Manufacturing
Open in API
Filings indexed 113 across all filing types
Latest filing 2018-02-14 Interim / Quarterly Rep…
Country JP Japan
Listing T 4565

About Nxera Pharma Co., Ltd.

https://www.nxera.life/

Nxera Pharma Co., Ltd. (formerly Sosei Group Corp.) is a technology-driven biopharmaceutical company focused on the discovery and early development of novel medicines. The company utilizes its proprietary StaR® technology and world-leading expertise in G protein-coupled receptor (GPCR) structure-based drug design (SBDD) to create therapeutics for diseases with high unmet medical needs. By integrating advanced science and technology, Nxera Pharma develops its internal pipeline and collaborates with partners to accelerate the creation of life-changing treatments for patients worldwide. Its mission is to invest in science and technology to accelerate the development of these medicines.

Recent filings

Filing Released Lang Actions
四半期報告書－第28期第3四半期(2017/10/01－2017/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Sosei Group Corporation, covering the third quarter of the 28th fiscal year (October 1, 2017, to December 31, 2017). It contains detailed financial statements, management analysis of financial results, and information on share capital and stock options. As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report. Q3 2018
2018-02-14 Japanese
訂正四半期報告書－第28期第2四半期(2017/07/01－2017/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Sosei Group Corporation, covering the second quarter of the 28th fiscal period (2017-07-01 to 2017-09-30). It contains detailed financial statements, management analysis, and corporate information as required by the Financial Instruments and Exchange Act of Japan. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2018
2018-02-14 Japanese
訂正四半期報告書－第28期第1四半期(2017/04/01－2017/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Sosei Group Corporation, covering the first quarter of the 28th fiscal year (April 1, 2017, to June 30, 2017). It contains detailed financial statements, management analysis, and corporate information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2017
2018-02-14 Japanese
訂正有価証券報告書－第27期(2016/04/01－2017/03/31)
Annual Report Classification · 100% confidence The document is a 'Correction Report' (訂正有価証券報告書) for a Securities Report (有価証券報告書), which is the Japanese equivalent of a 10-K. It contains detailed financial statements, management indicators, and corporate history for Sosei Group Corporation for the fiscal year ending March 31, 2017. Although it is a correction, it functions as the primary annual financial disclosure document. FY 2016
2018-02-14 Japanese
訂正四半期報告書－第27期第3四半期(2016/10/01－2016/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Sosei Group Corporation, covering the third quarter of the 27th fiscal period. It contains detailed financial statements, management analysis, and operational updates, which aligns with the definition of an Interim/Quarterly Report (IR). Although the title mentions 'Correction' (訂正), it is a full report containing substantive financial data rather than just a notification of a report. 9M 2017
2018-02-14 Japanese
訂正四半期報告書－第27期第2四半期(2016/07/01－2016/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Sosei Group Corporation, covering the second quarter of the 27th fiscal period (2016-07-01 to 2016-09-30). It contains detailed financial statements, management analysis (MDA), and operational updates, which aligns with the definition of an Interim/Quarterly Report (IR). Although the title mentions 'Correction' (訂正), the content is a comprehensive financial report rather than a simple announcement or certification. Q2 2016
2018-02-14 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.